Landos Biopharma, Inc.
Landos Biopharma, Inc. (LABP) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LABP · as of Mar 31, 2024
Ownership Breakdown
16
Institutional Holders
▲ 7 vs Q4
$34.93M
Total Inst. Value
▲ $29.34M vs Q4
3.13M
Shares Outstanding
freeFloat 42.54%
1.62M
13F Shares Held
▲ 96,976 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LABP largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
PERCEPTIVE ADVISORS LLC pharmaceutical preparations | 1.49M | 23.95% | 23.95% | $31.94B | Aug 6, 2024 | — held |
DELTEC ASSET MANAGEMENT LLC pharmaceutical preparations | 50.0K | 80.55% | 80.55% | $1.07B | Apr 17, 2024 | NEW |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 18.9K | 30.43% | 30.43% | $406.00M | May 13, 2024 | ▲ 7.6K |
MACQUARIE GROUP LTD pharmaceutical preparations | 14.7K | 23.71% | 23.71% | $316.00M | May 14, 2024 | — held |
VIRTU FINANCIAL LLC pharmaceutical preparations | 14.5K | 23.42% | 23.42% | $313.00M | May 20, 2024 | NEW |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 12.6K | 20.30% | 20.30% | $270.99M | May 13, 2024 | — held |
BLACK MAPLE CAPITAL MANAGEMENT LP pharmaceutical preparations | 10.4K | 16.76% | 16.76% | $223.50M | May 15, 2024 | NEW |
PENDERFUND CAPITAL MANAGEMENT LTD. pharmaceutical preparations | 9.3K | 14.98% | 14.98% | $270.84M | May 15, 2024 | NEW |
UBS GROUP AG pharmaceutical preparations | 4.1K | 6.58% | 6.58% | $87.72M | May 13, 2024 | ▲ 4.0K |
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 896 | 1.44% | 1.44% | $19.25M | May 15, 2024 | ▲ 896 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
4
Increased
+12.6K shares6
New Positions
first time holders0
Decreased
−0 shares1
Sold Out
fully exitedNet shares change (top 50)
+12.6K
+12.6K / −0
Net new holders
+9
6 new / 1 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LABP insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
21
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
MAYLEBEN TIMOTHY M director | May 23, 2024 | D-Return | 1,800 | $7.90 | $14.2K | 0 | Form 4 ↗ |
MAYLEBEN TIMOTHY M director | May 23, 2024 | D-Return | 1,800 | $3.30 | $5.9K | 0 | Form 4 ↗ |
Girao Tiago director | May 23, 2024 | D-Return | 1,800 | $6.40 | $11.5K | 0 | Form 4 ↗ |
Girao Tiago director | May 23, 2024 | D-Return | 1,800 | $3.30 | $5.9K | 0 | Form 4 ↗ |
Girao Tiago director | May 23, 2024 | D-Return | 1,800 | $9.10 | $16.4K | 0 | Form 4 ↗ |
Callori Fred director | May 23, 2024 | D-Return | 1,800 | $9.10 | $16.4K | 0 | Form 4 ↗ |
Callori Fred director | May 23, 2024 | D-Return | 1,800 | $6.40 | $11.5K | 0 | Form 4 ↗ |
Callori Fred director | May 23, 2024 | D-Return | 1,800 | $3.30 | $5.9K | 0 | Form 4 ↗ |
Batycky Alka director | May 23, 2024 | D-Return | 3,600 | $3.05 | $11.0K | 0 | Form 4 ↗ |
Adsett Roger director | May 23, 2024 | D-Return | 1,800 | $9.10 | $16.4K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Landos Biopharma, Inc. (LABP) is primarily owned by institutional investors, who hold approximately 51.9% of total shares outstanding. Company insiders own approximately 57.46%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Landos Biopharma, Inc. is PERCEPTIVE ADVISORS LLC, holding approximately 1.49 million shares — equal to 23.95% of outstanding shares — as of March 31, 2024.
A total of 16 institutional investors currently hold LABP stock, with a combined institutional value of approximately $34,926,893 as of the most recent 13F filing period.
Frequently asked questions
LABP ownershipLandos Biopharma, Inc. (LABP) is primarily owned by institutional investors, who hold approximately 51.9% of shares. The largest shareholder is PERCEPTIVE ADVISORS LLC with a 23.95% stake. Company insiders hold 57.46%. Data sourced from SEC Form 13F as of March 31, 2024.